
|
1 minute
|
TC BioPharm Work with University College London on Cancer Project
TC BioPharm have joined forces with University College London to develop treatment for Leukaemia.
The agreement aims to progress UCL’s gene-modified T cell therapies that are capable of treating cancers of the blood.
To read the full article, click here.